Customer/Partner Satisfaction Service Surveys

ICR 202206-0910-014

OMB: 0910-0360

Federal Form Document

Forms and Documents
Document
Name
Status
Justification for No Material/Nonsubstantive Change
2022-06-30
Justification for No Material/Nonsubstantive Change
2022-04-05
Justification for No Material/Nonsubstantive Change
2021-11-03
Justification for No Material/Nonsubstantive Change
2021-10-27
Supporting Statement B
2020-08-20
Supporting Statement A
2022-06-30
IC Document Collections
IC ID
Document
Title
Status
252859 Unchanged
252855 Unchanged
252061 Unchanged
251423 Unchanged
251250 Unchanged
251188 Unchanged
251007 Unchanged
250074 Unchanged
249808 Unchanged
249376 Unchanged
248333 Unchanged
248316 Unchanged
247695 Unchanged
246428 Unchanged
246076 Unchanged
244440 Unchanged
244195 Unchanged
244137 Unchanged
ICR Details
0910-0360 202206-0910-014
Received in OIRA 202204-0910-001
HHS/FDA Generic
Customer/Partner Satisfaction Service Surveys
No material or nonsubstantive change to a currently approved collection   No
Regular 06/30/2022
  Requested Previously Approved
10/31/2023 10/31/2023
83,100 83,100
30,900 30,900
0 0

This generic ICR will allow FDA to conduct customer satisfaction surveys to gain important feedback from all FDA-regulated industries.

EO: EO 12862 Name/Subject of EO: Setting Customer Service Standards
  
None

Not associated with rulemaking

  85 FR 3389 01/21/2020
85 FR 51449 08/20/2020
No

18
IC Title Form No. Form Name
CDRH Advisory Committee Satisfaction Survey
CDRH Customer Satisfaction Survey
Customer Satisfaction Surveys for FDA Food Safety Culture Webinar Series
FDA Food Industry Survey for Coronavirus Disease 2019 (COVID-19) Related Materials (OC)
FDA Food Industry Survey for Coronavirus Disease 2019 Related Materials (OC)
Feedback on Patient-Generated Health Data Workshop (CDRH)
Feedback on Virtual Course Title "IMPACT" Bootcamp: Navigating the Journey from Digital Health Technologies to Meaningful Patient Outcomes (CDRH)
Feedback on Virtual Course Titled "IMPACT Bootcamp: Navigating the Journey from Digital Health Technologies to Meaningful Patient Outcomes" (CDRH)
Food Industry Survey for Coronavirus Disease 2019 (COVID-19) Related Materials
Food and Drug Administration/ CFSAN and the U.S. Depr. of Agriculture /FAS Produce Safety Presentation Series for Produce Stakeholders in Latin America Followup Survey (CFSAN)
Interviews with Applicants and Other External Stakeholders Regarding Use of Patient Experience Data in Regulatory Decision Making (CDER)
Level 2 Training Course Evaluation (ORA)
Post-Course Satisfaction Evaluation (ORA)
Post-Event Survey for a Continuing Education (CE) Webinar on Pregnancy and Lactation Medication Information for the Healthcare Provider
Scholastic Vaping Education Materials Survey (CTP)
Sponsor and Payor Feedback for the Early Payor Feedback Program (CDRH)
State Program Satisfaction Survey for Remote Assessments (ORA)
U.S. President's Emergency Plan for AIDS Relief Database Customer Survey to Industry and External Stakeholders (CDER)

  Total Request Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 83,100 83,100 0 0 0 0
Annual Time Burden (Hours) 30,900 30,900 0 0 0 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
No
No
The Food and Drug Administration is submitting this nonmaterial/non-substantive change request to add 28,100 responses and 3,400 burden hours. No other changes are occurring. This generic clearance is used by various programs in all Centers within FDA, and because we anticipate more use of this generic approval over the next year, we therefore request an increase in responses and hours until the expiration date in 2023.

$2,181
Yes Part B of Supporting Statement
    Yes
    No
No
No
No
No
Jonna Capezzuto 301 796-3794 [email protected]

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
06/30/2022


© 2024 OMB.report | Privacy Policy